Exchange: NASDAQ·Updated 06:32 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

$0.01

Reported EPS

$0.00

Surprise

-100%

Estimated Rev

$238.11M

Reported Rev

$263.71M

Surprise

+10.75%

• Reported GAAP EPS of $0.00 • Reported revenue of $263.71M up 45.38% YoY • Caris Life Sciences now expects full year 2026 revenue to be in the range of $1.03 billion to $1.04 billion, representing growth of 27% to 28% compared to full year 2025.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.03
--
--
N/A
Q2 '26
$0.01
$0.00
-100.00%
MISSED
Q1 '26
-$0.02
$0.00
100.00%
BEAT
Q4 '25
$0.03
$0.28
723.07%
BEAT
Q3 '25
-$0.18
$0.08
145.67%
BEAT

Advertisement|Remove ads.